Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma
| Conditions: | Malignant Pleural Mesothelioma |
| Start Date: | May 1, 2007 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00484276 |
| Study Type: | Interventional |
| Intervention: | Drug: NGR-hTNF |
| Study Design: | Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | MolMed S.p.A. |
| Ages: | Adult|Senior |
| Enrollment: | 57 |
| Funded By: | Industry |
| First Received: | June 7, 2007 |
| End Date: | December 1, 2010 |
| Last Updated: | October 20, 2010 |
| Last Verified: | October 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
